decisionhealth Newsletters, Answer Books - 2006 Issue 3 (March)
Program_Memos / 2000 / AB-00-108
Subscribe or sign in to view the full article.
Article Overview
This article explains Medicare coverage and payment policy for glucose monitoring when a beneficiary is not in a Part A covered stay, with discussion of Part B billing in hospitals, skilled nursing facilities, and home health contexts. It also covers the transition to gap-filling for a laboratory fee schedule item, the role of CLIA-waived testing, and references to related Medicare manuals, claims forms, and federal coverage requirements. The content is aimed at providers, coders, intermediaries, carriers, and compliance staff who need to understand how the policy is administered and documented.
Why This Topic Matters
The memorandum clarifies how Medicare treats glucose monitoring across multiple care settings and how payment is handled under the laboratory fee schedule. It is important for determining whether claims fit the applicable coverage framework and for understanding the timing and implementation of fee schedule updates.
Article Sections
-
Overview
Introduces the Medicare policy review and the general setting in which glucose monitoring services are discussed. Summarizes the reason the memorandum was issued and the broader administrative context.
-
Glucose monitoring service and coverage background
Describes the service at a high level and discusses the medical, laboratory, and regulatory background relevant to coverage. References federal requirements, laboratory supervision concepts, and prior policy developments.
-
Hospital and skilled nursing facility payment guidance
Addresses how the service is handled when a beneficiary is in hospital or skilled nursing facility settings under Part B. Includes billing, revenue coding, and related payment considerations in those settings.
-
Home health payment guidance
Discusses the service in the home health setting and how it interacts with home health benefit rules. Covers when the service is included in the benefit and when separate laboratory payment is considered.
-
Separate quantitative glucose testing
Distinguishes the home-use monitoring service from another type of glucose laboratory test ordered in connection with evaluation and management care. Notes where related fee schedule instructions are found.
-
Clinical laboratory fee schedule and gap-filling
Explains the fee schedule status of the laboratory service and the need for carrier gap-filling for the referenced year. Discusses how the local fee amount is established and used for later national pricing.
-
Effective date and administrative notes
Provides the effective and implementation dates and final administrative instructions for handling claims and inquiries. Includes the retention period and contact information.
What You Will Learn
- The Medicare settings in which glucose monitoring is discussed
- How the memorandum relates to Part B coverage and payment policy
- The role of laboratory coverage criteria in different care settings
- How the article addresses fee schedule implementation and gap-filling
- Which Medicare manuals, forms, and federal authorities are referenced
Who Should Read This
- Medical coders
- Billing staff
- Compliance teams
- Intermediaries and carriers
- Home health agencies
- Skilled nursing facilities
- Hospital revenue cycle staff
- Physician practices
Codes Discussed
Code Ranges Discussed
Modifiers Discussed
Subscribe or sign in to view the full article.


Quick, Current, Complete - www.findacode.com